This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/12/2024
Operator
Conference Operator
Good afternoon and thank you for standing by. At this time, I'd like to welcome everyone to Zenon Pharmaceuticals Inc. 3rd Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number 1 on your telephone keypad. If you would like to withdraw your question, press star one again. Thank you. I will now turn the conference over to Chad Fugger, Vice President of Investor Relations.
Operator
Conference Operator
Please go ahead, sir.
Chad Fugger
Vice President of Investor Relations
Good afternoon. Thank you for joining us on our call and webcast to discuss Xenon's third quarter 2024 financial and operating results. Joining me today are Ian Mortimer, Xenon's President and Chief Executive Officer,
You're reading a preview of the XENE Q3 2024 earnings call.
Free account.
Disclaimer